A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

NCT07654374 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1100

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Chronic Weight Management
Type2 Diabetes Mellitus

Interventions

DRUG: aleniglipron
DRUG: aleniglipron
DRUG: aleniglipron
DRUG: Placebo

Sponsor

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics